Lipoprotein-associated phospholipase A2 (Lp-PLA2) – possible diagnostic and risk biomarker in chronic ischaemic heart disease-Reference-Cited by-同舟云学术

Lipoprotein-associated phospholipase A2 (Lp-PLA2) – possible diagnostic and risk biomarker in chronic ischaemic heart disease

Published:2020-11-13 Issue:1 Volume:36 Page:68-73
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Diaconu Adriana¹,Coculescu Bogdan-Ioan²³^ORCID,Manole Gheorghe⁴,Vultur Horațiu¹,Coculescu Elena Claudia⁵,Stocheci Cristina Maria⁶,Tudorache Ioan-Sorin²,Dincă Alexandra-Ligia⁷,Dincă Valeriu Gabi²

Affiliation:

1. Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

2. Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania

3. Center for Military Medical Scientific Research, Bucharest, Romania

4. Colentina Clinical Hospital, Bucharest, Romania

5. Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

6. Faculty of Sciences, University of Pitesti, Pitesti, Romania

7. Medicover Hospital, Bucharest, Romania

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2020.1839447

Reference27 articles.

1. Osteopontin – a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease

2. Manole G, General clinical pathophysiology. Pathophysiology organs. Bucharest (Romania): National Company Printers, Coresi S.A. Publishing; 2003. Romanian.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic inflammation factors as survival prognosis markers in ovarian neoplasm and the relationship with cancer-associated inflammatory mediators—a review;International Journal of Immunopathology and Pharmacology;2023-05-28

2. Adiponectin – stratification biomarker in diastolic cardiac dysfunction;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-01-24

3. The effects of fatty acid–based dietary interventions on circulating bioactive lipid levels as intermediate biomarkers of health, cardiovascular disease, and cardiovascular disease risk factors: a systematic review and meta-analysis of randomized clinical trials;Nutrition Reviews;2022-12-21

4. A retrospective study of immunoglobulin E as a biomarker for the diagnosis of acute ischemic stroke with carotid atherosclerotic plaques;PeerJ;2022-10-26

5. Investigating the effect of Fenofibrate on biomarkers of vascular inflammation in L-NAME induced hypertensive rats;Pharmacia;2022-05-19